{
    "2020-12-08": [
        [
            {
                "time": "",
                "original_text": "医药行业2021年度投资策略：需求无止境 供给共繁荣",
                "features": {
                    "keywords": [
                        "医药行业",
                        "2021年度",
                        "投资策略",
                        "需求",
                        "供给"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业2020年12月投资月报：医药反弹持续性如何？",
                "features": {
                    "keywords": [
                        "医药生物",
                        "2020年12月",
                        "投资月报",
                        "医药反弹",
                        "持续性"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "高瓴资本概念股再度活跃，金域医学、广联达、国瓷材料、泰格医药等普涨",
                "features": {
                    "keywords": [
                        "高瓴资本",
                        "概念股",
                        "金域医学",
                        "广联达",
                        "国瓷材料",
                        "泰格医药",
                        "普涨"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "国君医药 | 2021年度策略：需求无止境，供给共繁荣",
                "features": {
                    "keywords": [
                        "国君医药",
                        "2021年度",
                        "策略",
                        "需求",
                        "供给"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}